Arctic Root (Rhodiola rosea)
Adaptogenic herbal supplement for stress-related fatigue and mental performance
Quick Facts
Key Takeaways
- Arctic Root is an adaptogenic herbal supplement based on Rhodiola rosea, used for temporary relief of stress-related fatigue and reduced mental performance.
- The active compounds rosavins and salidroside are believed to modulate the body's stress response through the hypothalamic-pituitary-adrenal (HPA) axis.
- Clinical studies suggest improvements in fatigue, cognitive function, and stress resilience after 4-8 weeks of daily use.
- Arctic Root is generally well tolerated; the most common side effects are mild and include dizziness, dry mouth, and sleep disturbances.
- It should not be used during pregnancy or breastfeeding, and caution is advised when combined with antidepressants, blood thinners, or immunosuppressants.
What Is Arctic Root and What Is It Used For?
Arctic Root is a well-known adaptogenic herbal supplement derived from the root of Rhodiola rosea, a flowering plant that thrives in cold, mountainous regions of Europe, Asia, and North America. The plant has been used for centuries in traditional folk medicine, particularly in Scandinavian countries and Russia, where it was prized for its ability to help people withstand harsh climatic conditions and physical labor. Today, Arctic Root is one of the most extensively studied herbal adaptogens in the world.
The term "adaptogen" refers to a class of natural substances that are thought to help the body adapt to physical, chemical, and biological stressors. Unlike conventional stimulants, adaptogens do not cause a sharp spike in energy followed by a crash. Instead, they are believed to work by normalizing the body's physiological processes and helping to maintain homeostasis during periods of increased demand. Rhodiola rosea is one of the few plants to have received official recognition from the European Medicines Agency's Herbal Medicinal Products Committee (HMPC) for its traditional use in stress-related conditions.
The primary indication for Arctic Root is the temporary relief of symptoms associated with stress, such as fatigue, a sensation of weakness, exhaustion, and impaired cognitive function. It may also be used to support physical endurance during periods of increased physical demand, although clinical evidence for athletic performance enhancement remains more limited. Arctic Root is not intended for the treatment of clinical conditions such as major depressive disorder, chronic fatigue syndrome, or anxiety disorders, and should not be used as a substitute for medical treatment of these conditions.
The standardized extract in Arctic Root typically contains a defined ratio of the plant's key bioactive compounds: rosavins (minimum 3%) and salidroside (minimum 1%). These compounds are believed to be primarily responsible for the adaptogenic effects, although the full spectrum of the plant's over 140 identified chemical constituents likely contributes to its overall pharmacological profile. The 3:1 ratio of rosavins to salidroside reflects the natural ratio found in the root and is considered the hallmark of a high-quality Rhodiola rosea preparation.
Arctic Root is available as coated tablets and is sold over the counter without a prescription in most countries. It is classified as a traditional herbal medicinal product in the European Union and is listed in the European Pharmacopoeia. In the United States, Rhodiola rosea products are marketed as dietary supplements under the Dietary Supplement Health and Education Act (DSHEA).
What Should You Know Before Taking Arctic Root?
Although Arctic Root is an over-the-counter herbal product with a generally favorable safety profile, there are important considerations that should be understood before beginning supplementation. As with any pharmacologically active substance, the potential for adverse effects and drug interactions must be considered, particularly for individuals with pre-existing medical conditions or those taking prescription medications.
Contraindications
Arctic Root should not be used by individuals who have a known hypersensitivity or allergy to Rhodiola rosea or any of the excipients contained in the tablet formulation. Although allergic reactions are rare, they can include skin rash, itching, swelling, or in very rare cases, more severe hypersensitivity reactions. If any signs of an allergic reaction occur, use should be discontinued immediately and medical advice sought.
The use of Arctic Root during pregnancy and breastfeeding is not recommended due to insufficient safety data. While there are no established reports of teratogenic effects in animal studies at standard doses, the absence of controlled clinical trials in pregnant or lactating women means that the risk-benefit profile has not been adequately established. Women who are pregnant, planning to become pregnant, or breastfeeding should consult a healthcare provider before using any herbal supplement.
Arctic Root is not recommended for use in children and adolescents under 18 years of age due to a lack of clinical safety and efficacy data in this population.
Warnings and Precautions
Individuals with bipolar disorder should exercise caution when using Arctic Root, as the stimulatory properties of the supplement could theoretically trigger or exacerbate manic episodes. While this has not been systematically studied, case reports suggest that adaptogens with monoaminergic activity may carry this risk.
People with autoimmune conditions such as rheumatoid arthritis, lupus, or multiple sclerosis should consult their healthcare provider before using Arctic Root, as it may have immunomodulatory effects that could potentially influence disease activity. The immunostimulatory properties of Rhodiola rosea, while generally considered beneficial for healthy individuals, may be inappropriate for those whose immune system is already overactive.
If symptoms of stress-related fatigue persist beyond 2 weeks of use, or if symptoms worsen, a healthcare provider should be consulted. Stress-related fatigue can be a symptom of underlying medical conditions that require proper diagnosis and treatment, including thyroid disorders, anemia, depression, and sleep apnea.
Discontinue Arctic Root at least 2 weeks before any scheduled surgical procedure, as it may affect blood coagulation and interact with anesthetic agents. Inform your surgeon and anesthesiologist about all herbal supplements you are taking.
Pregnancy and Breastfeeding
The safety of Arctic Root during pregnancy has not been established through controlled clinical trials. While preclinical studies have not demonstrated clear evidence of harm at therapeutic doses, the absence of human data means that use during pregnancy cannot be recommended. The European Medicines Agency's HMPC monograph on Rhodiola rosea states that use during pregnancy and lactation is not recommended due to insufficient data.
Similarly, it is not known whether the active compounds in Arctic Root are excreted in breast milk. Given the potential for pharmacological effects on nursing infants, use during breastfeeding is not recommended unless specifically advised by a healthcare provider who has assessed the individual risk-benefit profile.
Women of childbearing age who are not using contraception should be aware of the lack of safety data and should discuss the use of Arctic Root with their healthcare provider before beginning supplementation.
How Does Arctic Root Interact with Other Drugs?
Drug interactions with herbal products can be challenging to predict because herbal extracts contain multiple pharmacologically active compounds that may affect drug metabolism, receptor binding, or physiological pathways. Rhodiola rosea has been shown to influence several neurotransmitter systems and enzymatic pathways that are relevant to drug metabolism, making the potential for clinically significant interactions an important consideration.
The primary concern relates to Rhodiola rosea's effects on monoamine neurotransmitters, including serotonin, dopamine, and norepinephrine. By influencing these pathways, Arctic Root may potentiate or modify the effects of medications that target the same systems. Additionally, some in vitro studies suggest that compounds in Rhodiola rosea may inhibit certain cytochrome P450 enzymes (CYP3A4, CYP2C9), which are involved in the metabolism of many commonly prescribed medications.
Major Interactions
The most clinically significant potential interactions involve medications that affect serotonin levels in the brain. Combining Arctic Root with selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine, sertraline, or citalopram may theoretically increase the risk of serotonin syndrome, a potentially life-threatening condition characterized by agitation, confusion, rapid heart rate, and elevated body temperature. While documented cases are limited, the theoretical basis for this interaction is well established.
Monoamine oxidase inhibitors (MAOIs) represent another category of significant concern. Rhodiola rosea has been reported to possess weak MAOI activity, and combining it with prescribed MAOIs could lead to excessive monoamine accumulation, potentially causing hypertensive crisis or serotonin syndrome. Patients taking MAOIs should avoid Arctic Root entirely.
| Medication Class | Examples | Interaction Risk | Mechanism |
|---|---|---|---|
| SSRIs | Fluoxetine, Sertraline, Citalopram | Major | Additive serotonergic effect; risk of serotonin syndrome |
| MAOIs | Phenelzine, Tranylcypromine | Major | Weak MAOI activity in Rhodiola; risk of hypertensive crisis |
| Anticoagulants | Warfarin, Heparin, DOACs | Moderate | Potential antiplatelet effects; may increase bleeding risk |
| Antihypertensives | ACE inhibitors, Beta-blockers, ARBs | Moderate | Additive blood pressure-lowering effects |
| Immunosuppressants | Cyclosporine, Tacrolimus, Methotrexate | Moderate | Immunostimulatory effects may counteract immunosuppression |
| CNS Stimulants | Methylphenidate, Amphetamine | Minor | Additive stimulatory effects; increased restlessness |
| Diabetes Medications | Metformin, Insulin, Sulfonylureas | Minor | May influence blood glucose regulation |
Minor Interactions
Arctic Root may have mild stimulatory properties, particularly when taken in higher doses. When combined with caffeine-containing products or other CNS stimulants, there is a theoretical risk of additive stimulation, which could manifest as increased restlessness, insomnia, irritability, or palpitations. While this is generally not dangerous in healthy individuals, it may be uncomfortable and can usually be managed by adjusting the timing or dosage of the supplement.
Some preclinical evidence suggests that Rhodiola rosea may have mild effects on blood glucose regulation. While clinical significance has not been established, people taking diabetes medications should monitor their blood glucose levels more closely when initiating Arctic Root supplementation. This precaution is particularly relevant for those taking insulin or sulfonylureas, where even modest changes in blood glucose could potentially lead to hypoglycemia.
Given the complexity of herbal-drug interactions, patients should always inform their healthcare provider and pharmacist about all herbal supplements they are taking. This is especially important before starting any new prescription medication or before undergoing surgical procedures.
What Is the Correct Dosage of Arctic Root?
The dosing of Arctic Root is based on the concentration of the standardized extract and the specific indication. The European Medicines Agency HMPC monograph provides guidance on traditional use dosing, while clinical research studies have used varying doses depending on the endpoints being investigated. It is important to follow the manufacturer's specific dosing instructions, as different products may contain different concentrations of the active extract.
Adults
Standard Adult Dosage
The recommended dose for adults (18 years and older) is typically 200 to 400 mg of standardized Rhodiola rosea extract per day, equivalent to one or two coated tablets depending on the product strength. The tablets should be taken in the morning or early afternoon, preferably 30 minutes before a meal, with a glass of water. Taking Arctic Root later in the day may cause sleep disturbances in sensitive individuals due to its mild stimulatory properties.
For stress-related fatigue, clinical studies have commonly used doses of 200 mg twice daily or 400 mg once daily for periods of 4 to 12 weeks. The HMPC monograph suggests a treatment duration of up to 2 weeks for traditional use indications, with reassessment if symptoms persist.
| Indication | Daily Dose | Duration | Notes |
|---|---|---|---|
| Stress-related fatigue | 200-400 mg | 2-12 weeks | Take in morning; reassess after 2 weeks |
| Cognitive performance support | 200-600 mg | 2-8 weeks | Higher doses used in research settings |
| Physical endurance | 200-400 mg | 4-8 weeks | Take 30-60 min before exercise |
| General well-being | 100-200 mg | Ongoing (cycle recommended) | Consider 6-8 week on / 1-2 week off cycles |
Children
Arctic Root is not recommended for use in children and adolescents under 18 years of age. There are no established clinical trials evaluating the safety or efficacy of Rhodiola rosea in pediatric populations. The developing nervous and endocrine systems of children may respond differently to adaptogenic substances, and the absence of pediatric safety data means that potential risks cannot be adequately assessed. Parents considering herbal supplements for children experiencing fatigue or stress should consult a pediatrician for appropriate evaluation and management.
Elderly
No specific dosage adjustment is generally required for elderly patients. However, older adults should start with the lowest effective dose (100-200 mg daily) and increase gradually if well tolerated. Elderly individuals may be more sensitive to the stimulatory effects of Arctic Root and more likely to be taking multiple medications, increasing the risk of drug interactions. A healthcare provider should be consulted before starting supplementation, particularly in those with cardiovascular conditions, hypertension, or those taking multiple prescription medications.
Missed Dose
If a dose of Arctic Root is missed, take it as soon as you remember, provided it is still early enough in the day (before mid-afternoon). If it is late in the afternoon or evening, skip the missed dose and resume your regular schedule the following morning. Do not take a double dose to make up for a missed one. Since Arctic Root is not treating an acute medical condition, missing an occasional dose is unlikely to have significant clinical consequences, though consistent daily use is recommended for optimal benefit.
Overdose
There are no well-documented cases of serious toxicity from Rhodiola rosea overdose in the published medical literature. In preclinical studies, the therapeutic index of Rhodiola rosea extract appears to be relatively wide, with adverse effects in animal models occurring only at doses many times higher than those used therapeutically. However, taking significantly more than the recommended dose may result in increased side effects including pronounced restlessness, insomnia, irritability, increased heart rate, and gastrointestinal discomfort.
In the event of accidental ingestion of a large quantity of Arctic Root tablets, symptomatic and supportive care should be provided. Contact a poison control center or seek medical attention if significant symptoms develop. There is no specific antidote for Rhodiola rosea overdose.
What Are the Side Effects of Arctic Root?
Clinical trials and post-marketing surveillance data indicate that Arctic Root has a favorable safety profile when used at recommended doses. The majority of reported side effects are mild to moderate in intensity and transient in nature, typically resolving without the need for treatment discontinuation. However, as with all pharmacologically active substances, individual responses can vary, and some people may experience effects that are more pronounced or persistent.
The side effect profile of Rhodiola rosea has been systematically evaluated in several randomized controlled trials involving a total of over 1,000 participants. In these studies, the incidence of adverse events in the treatment groups was generally comparable to that observed in placebo groups, suggesting a high degree of tolerability. The most commonly reported side effects are summarized below according to their approximate frequency.
Common
May affect up to 1 in 10 people
- Dizziness or lightheadedness
- Dry mouth
- Sleep disturbances (insomnia, vivid dreams) - especially when taken late in the day
- Mild gastrointestinal discomfort (nausea, stomach upset)
Uncommon
May affect up to 1 in 100 people
- Headache
- Restlessness or jitteriness
- Increased salivation
- Mild allergic skin reactions (rash, itching)
- Palpitations (sensation of rapid or irregular heartbeat)
Rare
May affect up to 1 in 1,000 people
- Changes in blood pressure (elevation or reduction)
- Mood changes (agitation, irritability, emotional lability)
- Hypersensitivity reactions (angioedema, urticaria)
It is important to note that the stimulatory properties of Rhodiola rosea, while generally desired for combating fatigue, may be experienced as uncomfortable side effects in some individuals. People who are sensitive to caffeine or other stimulants may be more likely to experience restlessness, insomnia, or palpitations with Arctic Root. Starting with a lower dose and gradually titrating upward can help to minimize these effects.
If you experience any side effects that are persistent, bothersome, or unexpected, discontinue use and consult a healthcare provider. Although serious adverse reactions are very rare, any signs of a severe allergic reaction (difficulty breathing, swelling of the face, lips, tongue, or throat) should be treated as a medical emergency.
If you experience any side effects from Arctic Root, including effects not listed here, you can report them to your national pharmacovigilance authority. In the United States, reports can be made to the FDA's MedWatch program. In the European Union, reports can be made through national agencies such as the MHRA (UK), BfArM (Germany), or ANSM (France). Reporting helps to build a more complete safety profile for herbal products.
How Should You Store Arctic Root?
Proper storage of herbal medicinal products is essential for maintaining their potency, safety, and quality throughout the shelf life of the product. The bioactive compounds in Rhodiola rosea extract, particularly rosavins and salidroside, can be sensitive to environmental factors such as heat, light, and moisture, which may lead to degradation and reduced efficacy over time.
Arctic Root coated tablets should be stored in their original packaging to protect them from light and moisture. The recommended storage temperature is below 25°C (77°F). The product should not be stored in bathrooms, kitchens, or other areas where temperature and humidity fluctuations are common. Do not transfer the tablets to a different container unless it provides equivalent protection from environmental factors.
Keep Arctic Root and all medications out of the sight and reach of children. Despite being a natural herbal product, accidental ingestion of large quantities by children could potentially cause adverse effects. Store the product in a secure location, ideally in a locked medicine cabinet or on a high shelf.
Do not use Arctic Root after the expiry date printed on the package. The expiry date refers to the last day of the stated month. Expired herbal products may have reduced potency and should be disposed of properly. Do not flush unused tablets down the toilet or pour them into drains. Consult your pharmacist about local medication disposal programs or return unused products to a pharmacy for proper disposal.
What Does Arctic Root Contain?
Understanding the composition of Arctic Root is important for individuals with allergies, sensitivities, or dietary restrictions. The product contains both the active herbal extract and various pharmaceutical excipients that serve functional roles in the tablet formulation.
Active Ingredient
The active ingredient in Arctic Root is a dry extract of Rhodiola rosea L. root (family Crassulaceae). The extract is standardized to contain a minimum of 3% total rosavins (rosavin, rosin, and rosarin) and 1% salidroside. This 3:1 ratio of rosavins to salidroside is characteristic of authentic Rhodiola rosea and serves as a quality marker to distinguish it from other Rhodiola species that may contain salidroside but lack rosavins.
The key bioactive compounds in Rhodiola rosea include:
- Rosavins (rosavin, rosin, rosarin) - Phenylpropanoid glycosides unique to Rhodiola rosea; considered primary markers of authenticity and quality.
- Salidroside (rhodioloside) - A phenylethanoid glycoside found in several Rhodiola species; believed to contribute significantly to adaptogenic activity.
- Tyrosol - A phenolic compound that is a metabolic precursor of salidroside.
- Flavonoids - Including rhodionin, rhodiolin, and others that may contribute to antioxidant properties.
- Monoterpenes - Including rosiridol, which contributes to the characteristic rose-like aroma of the root.
- Organic acids - Including gallic acid, caffeic acid, and chlorogenic acid.
Inactive Ingredients (Excipients)
The inactive ingredients in coated tablet formulations of Arctic Root typically include standard pharmaceutical excipients such as:
- Microcrystalline cellulose (tablet filler/binder)
- Croscarmellose sodium (disintegrant)
- Magnesium stearate (lubricant)
- Silicon dioxide (flow agent)
- Hypromellose (tablet coating)
- Titanium dioxide (coating colorant)
- Talc (coating agent)
The exact excipient composition may vary between manufacturers and product formulations. Individuals with known allergies or sensitivities to any of these ingredients should check the specific product label or consult a pharmacist before use. Most Arctic Root formulations are free from common allergens such as gluten, lactose, and artificial colors, but this should be confirmed with the specific product being used.
Frequently Asked Questions About Arctic Root
Arctic Root is an adaptogenic herbal supplement derived from the Rhodiola rosea plant. It is primarily used to help the body cope with physical and mental stress, reduce fatigue, and support cognitive performance during periods of stress. It has been used in traditional medicine in Scandinavia, Russia, and other northern regions for centuries. The European Medicines Agency recognizes its traditional use for the temporary relief of symptoms of stress, such as fatigue and a sensation of weakness.
Arctic Root is generally well tolerated when taken as directed. Clinical studies involving over 1,000 participants have demonstrated a favorable safety profile. Common side effects are mild and include dizziness, dry mouth, and sleep disturbances if taken late in the day. It is not recommended during pregnancy or breastfeeding. People taking antidepressants, blood thinners, or immunosuppressants should consult a healthcare provider before use.
Some people notice effects within the first few days of use, particularly for fatigue and mental clarity. However, the full adaptogenic benefits typically develop over 2-4 weeks of consistent daily use. Clinical studies have observed significant improvements in stress-related fatigue after 4-8 weeks of supplementation. For cognitive performance support, benefits may be noticeable sooner, with some studies showing improvements in mental work capacity within the first week.
Yes, Arctic Root is typically taken daily as a coated tablet. Most clinical studies have used daily dosing for periods of 4 to 12 weeks. Some practitioners recommend cycling - for example, taking it for 6-8 weeks followed by a 1-2 week break - though there is no strong clinical evidence mandating this approach. It is best taken in the morning or early afternoon to avoid potential sleep disturbances. If symptoms persist beyond 2 weeks of use, consult a healthcare provider.
Arctic Root may interact with several types of medications. It may enhance the effects of antidepressants (SSRIs, MAOIs) by influencing serotonin and dopamine pathways, potentially increasing the risk of serotonin syndrome. It may also interact with blood-thinning medications, antihypertensive drugs, and immunosuppressants. Always inform your healthcare provider about all supplements you are taking, especially before starting new medications or undergoing surgery.
Arctic Root is a specific branded product containing a standardized extract of Rhodiola rosea with defined levels of rosavins (minimum 3%) and salidroside (minimum 1%). The quality of Rhodiola products on the market can vary significantly. Key quality markers include the 3:1 ratio of rosavins to salidroside, verification of species identity (as some products may contain other Rhodiola species), and compliance with pharmacopoeia standards. Look for products that have been tested for authenticity and potency by independent laboratories.
References
This article is based on peer-reviewed scientific research, regulatory monographs, and international clinical guidelines. All medical claims are supported by evidence level 1A (systematic reviews and meta-analyses of randomized controlled trials) where available.
- European Medicines Agency (EMA). "Community herbal monograph on Rhodiola rosea L., rhizoma et radix." HMPC Assessment Report, EMA/HMPC/232091/2011. Updated 2012.
- Panossian A, Wikman G. "Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress-Protective Activity." Pharmaceuticals. 2010;3(1):188-224. doi:10.3390/ph3010188.
- Ishaque S, Shamseer L, Bukutu C, Vohra S. "Rhodiola rosea for physical and mental fatigue: a systematic review." BMC Complementary and Alternative Medicine. 2012;12:70. doi:10.1186/1472-6882-12-70.
- Cropley M, Banks AP, Boyle J. "The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms." Phytotherapy Research. 2015;29(12):1934-1939. doi:10.1002/ptr.5486.
- Anghelescu IG, Edwards D, Seifritz E, Kasper S. "Stress management and the role of Rhodiola rosea: a review." International Journal of Psychiatry in Clinical Practice. 2018;22(4):242-252. doi:10.1080/13651501.2017.1417442.
- Hung SK, Perry R, Ernst E. "The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials." Phytomedicine. 2011;18(4):235-244. doi:10.1016/j.phymed.2010.08.014.
- Olsson EM, von Schéele B, Panossian AG. "A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue." Planta Medica. 2009;75(2):105-112. doi:10.1055/s-0028-1088346.
- World Health Organization. "WHO Traditional Medicine Strategy 2014-2023." Geneva: WHO; 2013.
- European Pharmacopoeia Commission. "Rhodiola rosea root." European Pharmacopoeia, 10th edition. Strasbourg: EDQM Council of Europe; 2020.
- Panossian A, Hamm R, Kadioglu O, Wikman G, Efferth T. "Synergy and Antagonism of Active Constituents of ADAPT-232 Formula." Frontiers in Pharmacology. 2014;5:123. doi:10.3389/fphar.2014.00123.
Editorial Team
This article was written and reviewed by the iMedic Medical Editorial Team, comprising licensed physicians and pharmacologists with expertise in herbal medicine, pharmacology, and evidence-based medicine.
iMedic Medical Editorial Team. Content based on EMA/HMPC monograph, systematic reviews, and peer-reviewed clinical trials.
iMedic Medical Review Board. Independent review according to international guidelines (EMA, WHO) and GRADE evidence framework.
All content follows iMedic Editorial Standards. No commercial funding or pharmaceutical sponsorship.
This article is reviewed and updated regularly to reflect the latest scientific evidence and regulatory guidance. Last reviewed: .